STOCK TITAN

Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Third Harmonic Bio (Nasdaq: THRD), a clinical-stage biopharmaceutical company, announced that its CEO, Natalie Holles, will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2024, at 7:30 a.m. ET.

The event will be webcast live on the Third Harmonic Bio website, with a replay available for 90 days post-event.

The company focuses on developing treatments for dermal, respiratory, and gastrointestinal inflammatory diseases.

Loading...
Loading translation...

Positive

  • Participation in the Jefferies Global Healthcare Conference enhances visibility and credibility within the industry.
  • CEO Natalie Holles' involvement provides an opportunity for direct communication with investors and stakeholders.
  • Webcast availability and 90-day replay period increase access for interested parties, potentially broadening investor base.

Negative

  • No new financial data or clinical trial updates were provided in the PR, offering new actionable information for investors.
  • The announcement does not address any current challenges or risks the company may be facing.
Argus Session date unavailable
-1.61% session move Open Argus
Details

News Market Reaction – THRD

The recorded move for THRD in the trading session of this news was -1.61%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases, today announced that Chief Executive Officer, Natalie Holles, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 7:30 a.m. ET.

A live audio webcast will be available within the Investors & Media section of the Third Harmonic Bio website. An archived replay will be accessible for 90 days following the event.

About Third Harmonic Bio, Inc.
Third Harmonic Bio is a clinical stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases through the development of novel, highly selective, small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Early clinical studies demonstrate that KIT inhibition has the potential to revolutionize the treatment of a broad range of mast-cell-mediated inflammatory diseases, and that a titratable, oral small molecule inhibitor may provide the optimal therapeutic profile against this target. Third Harmonic Bio’s lead product candidate, THB335, is a titratable, oral, small molecule inhibitor that is currently in a Phase 1 clinical trial. For more information, please visit the Third Harmonic Bio website: www.thirdharmonicbio.com.

Investor and Media Contact:
Lori Murray
lori.murray@thirdharmonicbio.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Third Harmonic Bio participate in the Jefferies Global Healthcare Conference?

Third Harmonic Bio will participate in the Jefferies Global Healthcare Conference on June 5, 2024, at 7:30 a.m. ET.

Who will represent Third Harmonic Bio at the Jefferies Global Healthcare Conference?

CEO Natalie Holles will represent Third Harmonic Bio at the Jefferies Global Healthcare Conference.

How can I access the Third Harmonic Bio webcast from the Jefferies Global Healthcare Conference?

The webcast will be available on the Investors & Media section of the Third Harmonic Bio website, with a replay accessible for 90 days post-event.

What is the focus of Third Harmonic Bio's research and development?

Third Harmonic Bio focuses on developing treatments for dermal, respiratory, and gastrointestinal inflammatory diseases.

What is the stock symbol for Third Harmonic Bio?

The stock symbol for Third Harmonic Bio is THRD.

Keep reading